Insights

News

General
Celonic inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland
June 18, 2024
General
Celonic launches new GS-CHOvolution® Cell Line Expression System
March 18, 2024
Appointments, General
SAMANTA CIMITAN APPOINTED CHIEF EXECUTIVE OFFICER (CEO) AT CELONIC
August 2, 2023
Appointments, General
Samanta Cimitan Appointed Chief Business Officer at Celonic
May 31, 2022
General
CELONIC TO BECOME A LONG-TERM PARTNER OF THE FEDERAL REPUBLIC OF GERMANY FOR VACCINE SUPPLY
March 24, 2022
General
Celonic’s 2021 Milestones – Looking Beyond the Pandemic
January 19, 2022
General
Celonic’s manufacturing of diagnostics kits is closed
December 20, 2021
General
Conquering Milestones Together with Your CDMO Partner
November 22, 2021
General
Alexandre Pasini appointed Chief Operating Officer at Celonic
October 28, 2021
General
Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV
March 30, 2021
General
Celonic Group and University College London (UCL) Announce Partnership to Produce Protein Therapeutics using Celonic’s CHOvolution® Platform
March 22, 2021
General
Live webinar: Difficult-To-Express Protein?
November 18, 2020
General
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
July 29, 2020